<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pray For Paul &#187; Relating</title>
	<atom:link href="http://www.prayforpaul.com/tag/relating/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prayforpaul.com</link>
	<description>Diabetes &#38; Treament Questions</description>
	<lastBuildDate>Wed, 08 Feb 2012 18:57:41 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>Tethys Announces Issuance Of Key Patent Relating To PreDx™ Diabetes Risk Score Test</title>
		<link>http://www.prayforpaul.com/tethys-announces-issuance-of-key-patent-relating-to-predx%e2%84%a2-diabetes-risk-score-test/</link>
		<comments>http://www.prayforpaul.com/tethys-announces-issuance-of-key-patent-relating-to-predx%e2%84%a2-diabetes-risk-score-test/#comments</comments>
		<pubDate>Sun, 27 Jun 2010 18:56:20 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Type 2 Diabetes]]></category>
		<category><![CDATA[Announces]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[Issuance]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[PreDx™]]></category>
		<category><![CDATA[Relating]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[Score]]></category>
		<category><![CDATA[test]]></category>
		<category><![CDATA[Tethys]]></category>

		<guid isPermaLink="false">http://www.prayforpaul.com/tethys-announces-issuance-of-key-patent-relating-to-predx%e2%84%a2-diabetes-risk-score-test/</guid>
		<description><![CDATA[Tethys Announces Issuance Of Key Patent Relating To PreDx™ Diabetes Risk Score Test Tethys Bioscience, Inc., a privately held company, announced that the United States Patent and Trademark Office has granted the Company US Patent 7,723,050. The patent is directed to the company&#8217;s groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods [...]]]></description>
			<content:encoded><![CDATA[<p><b>Tethys Announces Issuance Of Key Patent Relating To PreDx™ Diabetes Risk Score Test</b><br />
Tethys Bioscience, Inc., a privately held company, announced that the United States Patent and Trademark Office has granted the Company US Patent 7,723,050. The patent is directed to the company&#8217;s groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition. Notably, this patent was issued following an &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.prayforpaul.com/tethys-announces-issuance-of-key-patent-relating-to-predx%e2%84%a2-diabetes-risk-score-test/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

